AMP Europe 2021: SIPMeT Session on Deregulation & Targeting in Cancer

Log in for pricing

(No reviews yet) Write a Review
SKU:
311EUR21-007



This is a recording of a session from AMP Europe 2021 Virtual Meeting. Purchase a bundle of 8 sessions from the AMP Europe 2021 Virtual Conference for a significant discount by clicking this link.


Session Description:

Cancer is characterized by both genetic and epigenetic alterations. While cancer driver mutations and copy-number alterations have been studied at a systems-level, relatively little is known about the systems-level patterns exhibited by their epigenetic counterparts. In this section speakers will perform a pan-cancer wide systems-level analysis, mapping candidate cancer-driver DNA methylation (DNAm) alterations onto a human interactome. The invited speakers demonstrate that functional DNAm alterations in cancer tend to map to nodes of lower connectivity and inter-connectivity, compared to the corresponding alterations at the genomic level. There are findings that epigenetic alterations are relatively over-represented in extracellular and transmembrane signaling domains, whereas cancer genes undergoing amplification or deletion tend to be enriched within the intracellular domain.


Chair: Dr. Massimiliano M. Corsi Romanelli

Presentations:

  • Targeting Epigenome in Cancer, Dr. Lucia Altucci

  • Deregulation of Hedgehog Signaling in Cancer: Targeting Epigenetic and Metabolic Vulnerabilities, Dr. Gianluca Canettieri


Duration: 50 minutes
Recording Date: June 18, 2021

Last day to purchase: December 31, 2024

There are no CME or CMLE credits available.

Note: Join the AMP Family for discounted access to the most current educational resources!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.